Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Kenneth McClain MD, PhD

Kenneth L. McClain MD, PhD

Professor of Pediatrics, Baylor College of Medicine, Texas Children’s Cancer and Hematology Centers, Houston, Texas

Dr. McClain received his MD and PhD from the University of Chicago, completed pediatric residency at the Johns Hopkins Hospital, and post-doctoral research training in the Laboratory of Molecular Genetics, Child Health Institute, National Institutes of Health. He has dedicated his clinical and research efforts on the histiocytic diseases for over 43 years beginning with his hematology/oncology fellowship at the University of Minnesota. Since 1986 he has been at the Texas Children’s Cancer Center in Houston where he is a Professor of Pediatrics. In 2001 he organized a Histiocytosis Center there and was joined by Dr. Carl Allen in 2006. Together they have developed a robust clinical program which has attracted many patients from around the world. Because of the large number of specimens collected from patients enrolled on research studies they have developed successful translational research studies with collaborators from several other institutions. LCH patients with neurologic dysfunction have been a special research interest leading to innovative therapies and new biologic understanding of this problem. Dr. McClain has cared for adult patients with histiocytic diseases for nearly 30 years. He is a past president of the Histiocyte Society and been a member of the education and scientific committees as well as worked with the Adult, HLH, LCH, and Rare Disease committees.


Dr. McClain is on the Medical Advisory Panel for SOBI Corporation and Atara Biotherapeutics.